Search research articles
Contact Us
Filters
Showing results (161-170 of 269) with videos related to
Page
of 27
Sort By:
Gut
|
May 4, 2015
Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease
Reena Khanna, Guangyong Zou, Geert D'Haens, et al.
Gut
|
November 2, 2016
Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials
Pieter Hindryckx, Barrett G Levesque, Tom Holvoet, et al.
Inflammatory Bowel Diseases
|
November 5, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease
Marla C Dubinsky, Geert D'Haens, Olivier Dewit, et al.
Inflammatory Bowel Diseases
|
January 25, 2024
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials
Geert D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, et al.
Gastroenterology
|
March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease
Silvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Inflammatory Bowel Diseases
|
November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report
Brian G Feagan, Marc Lémann, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis
|
February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
Walter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
The New England Journal of Medicine
|
April 16, 2010
Infliximab, azathioprine, or combination therapy for Crohn's disease
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, et al.
United European Gastroenterology Journal
|
October 11, 2024
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework
Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 2020
Long-term safety of vedolizumab for inflammatory bowel disease
Edward V Loftus, Brian G Feagan, Remo Panaccione, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 269) with videos related to
Sort By:
Page
of 27
Gut
|
May 4, 2015
Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease
Reena Khanna, Guangyong Zou, Geert D'Haens, et al.
Gut
|
November 2, 2016
Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials
Pieter Hindryckx, Barrett G Levesque, Tom Holvoet, et al.
Inflammatory Bowel Diseases
|
November 5, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease
Marla C Dubinsky, Geert D'Haens, Olivier Dewit, et al.
Inflammatory Bowel Diseases
|
January 25, 2024
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials
Geert D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, et al.
Gastroenterology
|
March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease
Silvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Inflammatory Bowel Diseases
|
November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report
Brian G Feagan, Marc Lémann, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis
|
February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
Walter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
The New England Journal of Medicine
|
April 16, 2010
Infliximab, azathioprine, or combination therapy for Crohn's disease
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, et al.
United European Gastroenterology Journal
|
October 11, 2024
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework
Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 2020
Long-term safety of vedolizumab for inflammatory bowel disease
Edward V Loftus, Brian G Feagan, Remo Panaccione, et al.
Page
of 27